Document Detail


Integrating hepatitis C services into existing HIV services: the experiences of a sample of U.S. drug treatment units.
MedLine Citation:
PMID:  15716639     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hepatitis C virus (HCV) is the most prevalent blood-borne infectious disease in the United States, especially among drug users, and coinfection with HIV is common. Because drug users are often medically underserved, drug treatment units are important sites of opportunity for providing services for these infectious diseases. Given the commonalities in the routes of transmission of HIV and HCV, and the fact that many drug treatment units have established an infrastructure to provide HIV services, some have suggested integrating HCV services into those already established for HIV. Using data collected in a telephone survey with 89 drug treatment units throughout the United States, this paper examines the extent to which drug treatment units have expanded their HIV services to include those for HCV, and the extent to which this expansion was facilitated by having HIV services in place. Overall, a greater proportion of methadone maintenance than drug-free treatment units provided services for HIV and HCV. The majority of units in both modalities that provided HIV- and HCV-related services expanded their HIV service delivery to include similar HCV services, and one third expanded all of their HIV services. A large number of these units, however, indicated that having an HIV service infrastructure did not facilitate this expansion, often because the units wanted to emphasize differences in the two viral infections. Policy makers and individual treatment units need to develop strategies that capitalize on existing infrastructures while maintaining the distinction between HIV and HCV primary and secondary prevention efforts.
Authors:
Shiela M Strauss; Janetta M Astone; Don C Des Jarlais; Holly Hagan
Related Documents :
14647049 - Impaired irs-1/pi3-kinase signaling in patients with hcv: a mechanism for increased pre...
19629529 - Evidence for a dominant major gene conferring predisposition to hepatitis c virus infec...
11319519 - Focal segmental glomerulosclerosis and hepatitis c virus: a case report.
15910559 - Systemic autoimmune diseases co-existing with chronic hepatitis c virus infection (the ...
16985299 - Prevalence of autoantibodies in patients with hepatitis c virus infection in oman.
15225419 - Studies on the allostimulatory function of dendritic cells from hcv-hiv-1 co-infected p...
7557849 - Induction of t-helper cell response to hepatitis b core antigen in chronic hepatitis b:...
17650019 - Poverty reduction and the hiv / aids epidemic in kenya:what are the core issues.
22244529 - Response rates of standard interferon therapy in chronic hcv patients of khyber pakhtun...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  AIDS patient care and STDs     Volume:  19     ISSN:  1087-2914     ISO Abbreviation:  AIDS Patient Care STDS     Publication Date:  2005 Feb 
Date Detail:
Created Date:  2005-02-17     Completed Date:  2005-04-20     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9607225     Medline TA:  AIDS Patient Care STDS     Country:  United States    
Other Details:
Languages:  eng     Pagination:  78-88     Citation Subset:  X    
Affiliation:
National Development and Research Institutes, Inc., New York, New York 10010, USA. strauss@ndri.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibodies, Viral / blood
Data Collection
Female
HIV Infections / diagnosis,  prevention & control*
Health Care Surveys
Health Personnel / education
Hepatitis C / diagnosis,  prevention & control*
Humans
Male
Patient Education as Topic
Preventive Health Services / organization & administration*
Substance Abuse Treatment Centers / organization & administration*
United States / epidemiology
Grant Support
ID/Acronym/Agency:
R01 DA13409/DA/NIDA NIH HHS
Chemical
Reg. No./Substance:
0/Antibodies, Viral

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Oral candidosis as a clinical marker of immune failure in patients with HIV/AIDS on HAART.
Next Document:  A brief mental health and substance abuse screener for persons with HIV.